LITERATURE
Determinanti genetici di fludarabina-resistenza
29/10/2013
Presentazione orale EHA 2013

Molecular profiling per i linfomi T periferici
21/1/2013
Studio diagnostico di fase 3

SF3B1: un nuovo marcatore della LLC a alto rischio
24/11/2011
Davide Rossi, M.D., Ph.D

Review: Regolazione del metabolismo del ferro
7/6/2011
Intervista prof.sa Camaschella

Nuovi bersagli terapeutici per le LAL dell’adulto
4/10/2010
Commento della Dr.sa Chiaretti

Microarray utili per la diagnosi delle leucemie
4/10/2010
Con un commento del prof. Foà



 Festa di fine anno 2013/2014  Manifestazione Rock Your School  Hematology Academy for South African Hematologists  EHA Learning Center  EMATOLOGIA IN PROGRESS  Critical insights on CLL and MCL from ASH 2013  5ta edizione del Master in Ematologia Pediatrica  Recita di Natale 2013  6° Highlights from EHA disponibile sul sito  Love is life  30 anni di allotrapianto presso l'Ematologia  Un Centro omnicomprensivo di Ematologia a Roma  Festa di fine anno della Scuola in Ospedale  La sala Data Manager dedicata a Daniela De Fazio  La Scuola in Ospedale si affaccia sulla rete  Progetto comune "Sapienza" e Harvard a Baghdad  Terapia della leucemia mieloide acuta (LAM)  A tutti i partecipanti della recita di Natale  Video: Expert overview dall’ASH 2012  Due presentazioni italiane alla Plenary dell'ASH  Servizio Prenotazioni Prime Visite non disponibile  Nuova unità di Allotrapianto in Ematologia  Brindisi natalizio  Iscrizione EHA ridotta per i giovani ematologi  Primo EHA-CSH Joint Symposium  Highlights from EHA 2012 – 5° edizione   “Diagnosi e terapia dei pazienti con linfoma  Riunione gruppo AIRC 5 x 1000  REPORT DA EHA-18, STOCCOLMA  Pillole dal 17° meeting EHA  Aggiornamento sul trapianto di cellule staminali  La mostra dei bambini della Scuola in Ospedale  Bando UNDER40 in HEMATOLOGY 2014  Riunione AIRC Progetto 5x1000  EHA: Upcoming events and deadlines  Il Natale 2011 al Reparto Pediatrico  Sviluppi terapeutici nella leucemia mieloide acuta  Genetica della LLC, dei linfomi e della LAM  Quasi 1.000.000 di pagine consultate ad ottobre  Report: New Paradigms in ITP  Prof. Foà: vita di ricercatore  LAL pediatriche: dall’AIEOP all’America Latina  Borsa di studio “Associazione Cristina Bassi”  4° Highlights from EHA disponibile sul sito  16th EHA meeting: London 2011  La malattia di von Willebrand  Accessi venosi a medio termine  Ematologia in progress  Recita di Natale 2010  Appunti da Orlando  Master in Ematologia Pediatrica 2010-2011  ...ancora appunti dall'ASH  ...appunti dall'ASH  Associazione Cristina Bassi onlus  Master in Ematologia Pediatrica 2010-2011  3° Highlights from EHA sul sito  Dai linfomi ALK+ alla LAM con mutazione di NPM1  Translational Research Training in Hematology  La Telemedicina per i tumori dei bambini in Iraq  15° Congresso dell'EHA a Barcellona  7th Baltic Conference of Hematology  Coordinamento per i trapianti nel Lazio  Intervista: Vinto il bando 5x1000 AIRC  Sul sito i protocolli attivi nel nostro Istituto  Il nostro Centro vince il bando AIRC 5x1000  Intervista: L'ematologia pediatrica in Italia  Rassegna della letteratura  Intervista: La genetica delle leucemie  Report: Focus on Hemoglobinopathies and Leukemias  MEETING E CONVEGNI  l'ARTICOLO DEL MESE  INTERVISTE  ARCHIVIO NEWS



<< NOVEMBRE 2014 >>
Lun  Mar  Mer  Gio  Ven  Sab  Dom 
         
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
       

European Hematology Association

haematologica
the hematology journal

News  > Challenges in CLL today
Contents and Documents 
Contents and Documents 
Nessuna Informazione

Rome, May 14-15, 2010

Challenges in CLL today

Prof. Roberto Foà

(24/6/2013)


On May 14th and 15th we had the pleasure of hosting at our Center in Rome 18 hematologists, from different cities of the Turkish Republic, to attend the course: “Challenges in CLL today”. The purpose was to underline and discuss the remarkable changes that have occurred in this disease – which represents the most frequent leukemia in the western hemisphere – over the last decade. This has led to progressive and impressive advancements in our knowledge of the biology of CLL and, in turn, to profound changes in the management of patients suffering from this disease.


The group of the Turkish colleagues was accompanied by Prof. Mehmet Ali Ozcan, from the Izmir “9 Eylul” University. Throughout the two-day course, several aspects of CLL, such as a correct diagnostic classification, a precise differential diagnosis with other related conditions, the role and impact of a biologically-based prognostic stratifications and the relevance of such markers in the clinical management were actively discussed. Important issues, such as epidemiology, life expectancies, quality of life, etc were also covered. The second day was dedicated to the treatment of patients with CLL, from ‘conventional’ treatment to innovative approaches. The broad therapeutic armamentarium available and the different treatment options nowadays possible, including allogeneic and autologous hematopoietic stem cell transplant procedures, were discussed. Attention was paid also to the overall management currently ongoing in Turkey. All the above were achieved through oral lessons, interactive discussions and clinical case presentations prepared both by the Faculty and by our Turkish colleagues.



Each day, two hours were dedicated to a practical session. The participants, divided in 3 small groups, had the opportunity of visiting the different laboratories in function at the Hematology Center in Rome. These included in particular the flow cytometry laboratory and the molecular genetics laboratories, with a special focus on the new array-based technologies (gene profiling, p53 sequencing, etc). Particular emphasis was given to show on practical grounds what the laboratories can offer today in support to the clinicians in terms of diagnosis, prognosis and monitoring of minimal residual disease, as well as in terms of an always growing understanding of the biology of CLL. The close interaction between the clinic and the laboratories for an optimal management of patients with CLL was repeatedly underlined.
Finally, specific clinical scenarios, such as spontaneous regressions of CLL and monoclonal B-cell lymphocytosis, were presented and discussed as further examples of the ‘unicity’ of this disease.
All participants underlined the very warm and interactive atmosphere between all participants.

The close relationship with Turkish hematologists and with the Turkish Society of Hematology is further documented by the EHA-ESH Tutorial on “Lymphoid Malignancies” that took place in Kayseri in September 2009 and by the forthcoming Tutorial on “Myeloid Malignancies” that will be held in Istanbul on June 25-27, 2010, as well as on other joint activities that are in the pipeline.

Robin Foà

© 2007-2014 Clinica Ematologica dell'Universitą di Roma "La Sapienza" Ver. 6.4.0 del 22/4/2014 by Sinaptica IT S.r.l.
  Webmaster